BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 85 filers reported holding BEAM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,168,515 | -34.9% | 136,137 | -16.9% | 0.13% | -35.2% |
| Q4 2022 | $6,405,827 | +21.8% | 163,790 | +48.3% | 0.20% | +14.0% |
| Q3 2022 | $5,261,000 | +67.9% | 110,435 | +36.5% | 0.17% | +60.7% |
| Q2 2022 | $3,133,000 | -49.5% | 80,928 | -25.2% | 0.11% | -30.5% |
| Q1 2022 | $6,201,000 | -6.7% | 108,227 | +29.8% | 0.15% | +12.4% |
| Q4 2021 | $6,646,000 | -15.9% | 83,392 | -8.2% | 0.14% | -8.7% |
| Q3 2021 | $7,904,000 | -40.1% | 90,840 | -11.4% | 0.15% | -39.0% |
| Q2 2021 | $13,196,000 | +70.7% | 102,523 | +6.1% | 0.25% | +50.0% |
| Q1 2021 | $7,731,000 | -17.0% | 96,591 | -15.3% | 0.16% | -21.5% |
| Q4 2020 | $9,312,000 | +296.9% | 114,058 | +19.7% | 0.21% | +161.2% |
| Q3 2020 | $2,346,000 | -13.3% | 95,285 | -1.4% | 0.08% | -18.4% |
| Q2 2020 | $2,705,000 | +52.9% | 96,598 | -1.7% | 0.10% | +3.2% |
| Q1 2020 | $1,769,000 | – | 98,276 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |